已收盘 09-11 16:00:00 美东时间
-0.210
-3.46%
Mr. Subramanian brings more than 20 years of finance, capital markets, business development and operational leadership experience across the biotechnology, pharmaceutical and healthcare sectors. Most recently, he served as Chief Financial Officer and Head of Business Development at Inozyme Pharma, w...
09-10 20:01
SCYNEXIS, Inc. announced the appointment of Sanjay Subramanian as Chief Financial Officer, effective September 9, 2026, succeeding Ivor Macleod, who is retiring. Subramanian brings over 20 years of experience in finance and business development across the biotech and pharmaceutical sectors. Macleod, who joined SCYNEXIS in 2022, will remain through October 9 to ensure a smooth transition. Subramanian was granted an option to purchase 100,000 share...
09-10 12:00
For the Seventh Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC, Aug. 17, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYS...
08-17 20:00
LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company"), today announced that its CEO, Thomas J. Appio, has been appoint...
08-06 19:04
科技巨头资本开支“修复”AI信仰!铠侠ADR暴涨31%;微软财报凸显人工智能用电需求,燃料电池能源飙升30%;MKTX升逾29%,获纽交所母公司洲际交易所溢价收购>>
07-31 19:06
Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.06 by 17.76 percent. This is a 38.46 percent increase over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $2.852 billi...
07-30 04:08
PrOKEDI® is a prolonged-release injectable suspension of risperidone indicated for the treatment of schizophrenia in adults. According to the Canadian product monograph, PrOKEDI® achieves clinically relevant concentrations of the active ingredient within the first few hours after injection, without ...
07-06 19:22
Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA), resulting in a
06-09 20:07